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Abstract 
Background: Transcranial Doppler (TCD) is widely used to  detect  and  follow  up  cerebral  
vasospasm  after  sub- arachnoid  hemorrhage  (SAH). Therapeutic hypothermia might influence blood 
flow velocities assessed by TCD. The aim of the study was to evaluate the effect of hypo- thermia on 
Doppler blood flow velocity after SAH. 
Methods: In 20 patients treated with hypothermia (33°) due to refractory intracranial hypertension or 
delayed cerebral ischemia (DCI), mean flow velocity of the middle cerebral artery (MFVMCA) was 
assessed by TCD. Thirteen patients were treated with combined hypothermia and barbiturate coma 
and seven with hypothermia alone. MFVMCA was obtained within 24 h before and after induction of 
hypothermia as well as before and after rewarming. 
Results: Hypothermia was induced on average 5 days after SAH (range 1–12) and maintained for 144 
h (range 29–270). After hypothermia induction, MFVMCA  decreased from 113.7 ± 49.0  to  93.8 ± 
44.7 cm/s  (p = 0.001).  The decrease was independent of SAH-related complications and barbiturate 
coma. MFVMCA further decreased by 28.2 cm/s between early and late hypothermia (p < 0.001). This 
second decrease was observed in patients with DCI (p < 0.001), but not in patients with intracranial 
hypertension (p = 0.715). Compared to late hypothermia, MFVMCA remained unchanged after 
rewarming (65.6 ± 32.1 vs 70.3 ± 36.8 cm/s; p = 0.219). However, patients treated with hypothermia 
alone showed an increase in MFVMCA after rewarming (p = 0.016). 
Conclusion: Therapeutic hypothermia after SAH decrea- ses Doppler blood flow velocity in both 
intracranial hypertension and DCI cases. The results can be the effect of hypothermia-related 
mechanisms or resolving cerebral vasospasm during prolonged hypothermia. 
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Introduction 
Refractory high intracranial pressure (ICP) and delayed cerebral ischemia (DCI) are the most 
important causes of secondary brain injury after aneurysmal subarachnoid hemorrhage (SAH) [1, 2]. 
Recent animal studies have demonstrated that mild hypothermia (32–34 °C) has the potential to limit 
the extent of secondary brain injury by reversing acute cerebral perfusion pressure-independent 
hypoperfusion [3, 4], preventing brain edema formation [5, 6], and reducing cerebral vasospasm [7]. 
However, short- term hypothermia during aneurysm surgery failed to improve outcome in patients with 
good-grade SAH [8], suggesting that only a carefully selected group of patients with severe SAH 
suffering from intracranial hypertension and/or DCI might benefit from prolonged hypothermia 
treatment [9–11]. 
Although mild hypothermia likely interferes with a variety of processes leading to secondary brain 
injury, the most prevalent neuroprotective effect has been attributed to the suppression of cerebral 
metabolic oxygen and glucose demand [12, 13]. As a consequence, hypothermia has consistently 
been associated with reduced cerebral blood flow (CBF) under physiological conditions [14, 15]. 
However, CBF measurements during hypothermia in patients with acute brain injury are conflicting 
and the existing data are mainly limited to patients with traumatic brain injury [16–18]. The aim of this 
study was to evaluate changes in blood flow velocities via transcranial Doppler (TCD) sonography in 
patients with severe SAH who were treated with prolonged hypothermia due to refractory high ICP or 
DCI. 
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Materials and Methods 
 
Patient Characteristics and Management 
Between January 2007 and November 2010, 246 patients with SAH were admitted to the 
Neurointensive Care Unit, University Hospital Zurich. Of these, 46 patients with hypothermia treatment 
due to refractory high ICP or DCI were retrospectively identified from a prospective obser- vational 
database approved by the local ethics committee. Thirty-eight of them underwent TCD examination 
within 24 h before induction of hypothermia. Patients with induction of hypothermia during already 
initiated barbiturate coma  (n = 4)  or  immediately  after  endovascular treatment of cerebral 
vasospasm (n = 14) were excluded from the study. 
Patients were managed according to a standardized pro- tocol [10, 19]. Treatment of high ICP (>20 
mmHg) consisted of cerebrospinal fluid drainage and osmotherapy (mannitol 20 %, hypertonic NaCl-
hydroxyethyl-starch solution). Primary decompressive craniectomy was performed if signs of severe 
brain swelling were present during or immediately after aneurysm surgery and secondary de- 
compressive craniectomy if elevated ICP was refractory to maximal medical treatment. The presence 
of DCI was clinically defined as secondary neurological deficit or radiological evidence o a delayed 
cerebral infarction. Cerebral vasospasm was confirmed or ruled out by regular catheter angiography. 
All patients were treated with oral nimodipine. Hypertensive therapy (systolic blood pressure 
>150 mmHg) was initiated if signs of DCI were apparent. If patients did not improve, balloon 
angioplasty and/or super- selective papaverine infusion were performed. Hypothermia alone or in 
combination with barbiturate coma was applied as treatment of last resort if high ICP or DCI were 
refractory despite the above-mentioned treatment. 
Hypothermia (target temperature 33.0–33.9 °C) was induced and maintained by endovascular cooling 
(QuattroTM, Zoll Medical, Chelmsford, USA). In patients without contraindications for barbiturates, 
hypothermia was induced simultaneously with barbiturate coma. The thiopental loading dose was 10 
mg/kg, followed by a continuous infusion adapted to an electroencephalographic (EEG) burst 
suppression pattern. Hypothermia and barbiturate coma were maintained until ICP normalized, DCI 
resolved or severe side effects occurred. Rewarming was performed ICP-controlled and no faster than 
1 °C per 24 h. 
 
 
Physiological Measurements 
The following physiological parameters were obtained within  24 h  before  induction  of  hypothermia  
(Pre-HT, >35 °C), after reaching hypothermia (Early-HT, 33 °C), before rewarming (Late-HT, 33 °C), 
and after rewarming to normothermia (Post-HT, >35 °C): mean flow velocity in both middle cerebral 
arteries (MFVMCA), ICP, body core temperature (BCT), mean arterial pressure (MAP), arterial carbon 
dioxide tension (PaCO2), and hematocrit (HCT). Measurement values were obtained on average 7 h 
before hypothermia, 15 h after reaching hypothermia and 14 h before rewarming. Post-treatment 
values were available in 14 patients and obtained on average 9 h after reaching normothermia. 
Bilateral MFVMCA was measured by transcranial color- coded duplex sonography with a 2-MHz probe 
(ACUSON 2000TM, Siemens Healthcare, Germany). TCD examinations were performed daily by an 
independent neuroradiologist according to the method developed by Aaslid et al. [20]. The best signal 
obtained was insonated at a depth between 50 and 60 mm, and the mean flow velocity recorded from 
serial TCD. In healthy adults average MFVMCA is in the range of 73 ± 25 cm/s [21]. All patients had a 
ventricular catheter (Neurovent®, Raumedic AG, Germany) or intraparenchymatous probe 
(Neurovent-P®, Raumedic AG, Germany or BactisealTM, Codman, Johnson & Johnson; USA) for 
continuous ICP monitoring. BCT and MAP were measured via a thermistor-tipped femoral arterial 
catheter. Blood gas analysis for determination of PaCO2 and HCT was performed via the same 
arterial line. 
 
 
Statistical Analysis 
Mean values of physiological parameters were compared by paired t test. Patients were classified 
according to spe- cific SAH-related complications (ICP- vs DCI-group) and treatment protocol 
(combined hypothermia and barbiturate coma (cHTBC-group) versus hypothermia alone (HT- group)). 
Intergroup differences were compared by Mann– Whitney U test and Fisher’s exact test. The relation 
between mean differences in MFVMCA and MAP, PaCO2, and ICP were determined by linear 
regression analysis with calculation of the Pearson correlation coefficient. A p value <0.05 was 
considered statistically significant. 
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Results 
A total of 20 patients were included in this study. Clinical and treatment characteristics are 
summarized in Table 1. The overall incidence of severe SAH according to the World Federation of 
Neurological Surgeon (WFNS) grades 4–5 and Fisher scores 3–4 was 50 and 95 %, respectively. 
Hypothermia was induced on average 5 days after SAH (range 1–12) and maintained for 144 h (range 
29–270). The overall in-hospital mortality rate was 15 %. Hypothermia was induced earlier in the ICP-
group compared to the DCI-group (p = 0.002). Otherwise, there were no significant intergroup 
differences with regards to patients’ age, admission scores, specific SAH- related complications, 
treatment protocol, duration of hypothermia, and outcome. The 12-month outcome according to the 
Glasgow Outcome Scale (GOS) showed favorable outcome (GOS 4–5) in 40 % (n = 8), severe 
disability (GOS 3) in 35 % (n = 7), and death (GOS 1) in 25 % (n = 5). 
 
 
Effects of Hypothermia on Physiological Parameters 
A total of 148 MFVMCA values were available from bilateral TCD examinations. MFVMCA was 
available in all patients before hypothermia (40 values), early after reaching hypothermia (40 values), 
and before rewarming during late hypothermia (40 values). After rewarming to normothermia 
MFVMCA was available in 14 patients (28 values). The mean values of physiological parameters are 
summarized in Table 2. Mean MFVMCA decreased significantly by 19.8 cm/sec after hypothermia   
induction (p = 0.001) and remained unchanged after rewarming (p = 0.219) (Fig. 1). Likewise, mean 
ICP decreased  by 5.6 mmHg after hypothermia induction (p < 0.001) and remained unchanged after 
rewarming (p = 0.176). There were no significant changes in mean MAP, PaCO2, and HCT after 
hypothermia induction and after rewarming. There was no significant correlation between changes in 
MFVMCA and MAP (95 % CI -0.3 to 0.4, p = 0.749) and PaCO2 (95 % CI -0.1 to 0.5, p = 0.204). The 
correlation between changes in MFVMCA and ICP was statistically significant (95 % CI 0.0–0.6, p = 
0.048). 
The following changes in physiological parameters were observed between early and late 
hypothermia: MFVMCA decreased   by   28.2 cm/s   (95 %   CI   -43.6   to   -12.3, p = 0.0007) and 
PaCO2 increased by 0.6 kPa (95 % CI 0.4–0.9, p = 0.0002). There were no significant changes in 
Effect of Hypothermia on MFVMCA According to Patient Subgroups Mean MFVMCA for the patients’ 
subgroups according to specific SAH-related complications and treatment protocol are shown in Table 
3. Hypothermia was induced due to refractory high ICP in 9 patients and DCI in 11 patients. MFVMCA 
before hypothermia and during early hypother- mia was significantly higher in the DCI-group compared 
to the ICP-group (p = 0.002 and 0.003, respectively). After induction of hypothermia, MFVMCA 
significantly decreased in both the ICP-group (p = 0.016) and the DCI- group (p = 0.023, Fig. 2a). 
Between early and late hypothermia, MFVMCA significantly decreased in the DCI- group (95 % CI 
25.6–72.8, p < 0.001), but remained unchanged in the ICP-group (95 % CI -14.6 to 10.4, p = 0.724). 
MFVMCA remained unchanged after rewarming to normothermia in both, the ICP-group (p = 0.564) 
and the DCI-group (p = 0.198). 
Thirteen patients were treated with combined hypothermia and barbiturate coma (cHTBC-group) and 7 
patients with hypothermia alone (HT-group) due to contraindications for barbiturates. There were no 
significant differences in MFVMCA between both groups during the study (Table 3). After induction of 
hypothermia, MFVMCA significantly decreased in both the cHTBC-group (p = 0.020) and the HT-
group (p = 0.013, 
Fig. 2b). MFVMCA further decreased between early and late hypothermia in the cHTBC-group (95 
%CI  3.9–45.7, p = 0.022) and the HT-group (95 % CI 2.6–21.6, p = 0.017). 
After rewarming to normothermia, MFVMCA increased in the HT-group (p = 0.016), but remained 
unchanged in the cHTBC-group (p = 0.822). In 10 patients barbiturate administration was discontinued 
before rewarming (on average 48 h before, range 16–164) and in 3 patients after rewarming (on 
average 60 h post rewarming, range 30–87). 
 
 
Discussion 
The goal of this study was to evaluate the effect of hypo-thermia on blood flow velocity in patients with 
SAH via TCD. Mean differences in MFVMCA were used to estimate relative changes in CBF, as 
previously reported [22–24]. However, the expected linear relationship between MFVMCA and CBF 
only applies if the angle of isonation and blood vessel diameter remains constant (MFVMCA = 
CBF/angle of isonation * vessel diameter). 
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The variations in the angle of isonation were minimized by using transcranial color-coded duplex 
sonography, a technique reported to improve consistency and accuracy of TCD [25]. In addition the 
diameter of the proximal segment of the middle cerebral artery has been shown to remain constant 
during moderate changes in MAP and PaCO2 [26, 27]. However, vasospasm of the middle cerebral 
artery is frequently observed after  SAH  and  may increase MFVMCA, as confirmed previously [28]. If 
TCD is performed serially after SAH there is usually a steady rise in blood flow velocity with peak 
values around 1 week from SAH and recovery back to normal values over another week, reflecting the 
time course of pathological changes in arteries occurring during cerebral vasospasm [29]. Therefore, 
the results of this study need to be inter- preted with particular care, as mean differences in MFVMCA 
might indicate (1) relative changes in CBF and/ or (2) dynamic changes during cerebral vasospasm. 
In the current study, the decrease in MFVMCA after induction of hypothermia was independent of the 
indica- tion for hypothermia (high ICP or DCI), as well as from blood pressure, PaCO2, and 
hematocrit. This suggests that 
a lower body temperature (33 °C) itself is an important determinant of reduced blood flow velocities 
and possibly reflects lower CBF. Simultaneous induction of barbiturate coma may partly explain the 
decrease in MFVMCA in our patients. Barbiturates substantially reduce cerebral metabolism and, as a 
consequence, can lead to a decrease in CBF [30, 31]. Furthermore, hypothermia prolongs the duration 
of barbiturate-induced burst suppression pattern on EEG [32], possibly reflecting the unchanged 
MFVMCA after rewarming in patients with combined hypothermia and barbiturate coma. However, 
decreased MFVMCA after induction of hypothermia together with increased MFVMCA after rewarming 
in patients treated with hypothermia alone may suggest an independent temperature effect on CBF. 
Although the occurrence of cerebral vasospasm very likely influenced the absolute MFVMCA values, 
relative changes in MFVMCA after both induction of hypothermia (on average 5 days after SAH) and 
rewarming to normothermia (on average 13 days after SAH) were opposite to the time course of 
pathological changes in arteries after SAH. Finally, the study confirms previous reports on ICP 
reductions during hypothermia in patients with acute brain injury [16–18, 33]. In order to avoid rebound 
of ICP, rewarming should be performed ICP-controlled and no faster than 0.5–1 °C per 24 h. 
Furthermore, an abnormal increase in Doppler blood flow velocities during rewarming may serve as an 
index in the prediction of acute brain swelling, undermining the use of TCD as a rapid and noninvasive 
method to monitor cerebral hemodynamics during hypothermia [34]. 
Hypothermia is a therapeutic approach that likely interferes with a variety of processes leading to 
secondary brain injury, of these the suppression of cerebral metabolic rates of oxygen and glucose 
has been regarded as its most prevalent neuroprotective effect [12]. As a consequence, it is well 
known that hypothermia can lead to a reduction in CBF under physiological conditions [13, 14]. In 
juvenile pigs on cardiopulmonary bypass, Ehrlich et al. [15] demonstrated that flow-metabolism 
coupling was maintained and cerebrovascular resistance increased when body temperature was 
lowered from 37 to 28 °C. The findings of the current study support the physiological model of reduced 
CBF during hypothermia. Furthermore, the significant correlation between changes in MFVMCA and 
ICP might enhance the concept of increased cerebrovascular resis- tance during hypothermia [35]. 
Although the exact mechanisms of hypothermia-related ICP reductions remain to be elucidated, 
increased cerebrovascular resistance leading to reduced cerebral blood volume, and thus to reduced 
ICP, has been demonstrated previously [36]. Given the lack of controlled studies, no general 
recommendation for therapeutic hypothermia after SAH can currently be made. However, favorable 
outcome in 40 % of our patients may further support previous reports that patients with most severe 
SAH having refractory intracranial hypertension or DCI may benefit from prolonged hypothermia 
treatment [9, 10]. 
Hypothermia-related CBF reductions after acute brain injury are consistent with most [16, 17, 37, 38] 
but not all [18, 39] clinical studies, a possible reflection of the time point of hypothermia induction and 
different causes of primary brain injury. Shiozaki et al. [17] described a reduction in CBF by 15.4 
ml/100 g/min during hypothermia in 5 patients developing refractory intracranial hypertension within 48 
h after traumatic brain injury. On the other hand, Metz et al. [18] reported no change in CBF in 10 
patients with traumatic brain injury after induction of hypothermia immediately after hospital admission. 
In our study, hypothermia was induced on average 5 days after SAH, when intracranial hypertension 
or DCI was refractory to conventional treatment. This might suggest that these results are independent 
of the impact of primary brain injury in the majority of patients, and thus might reflect true hypothermia- 
related changes on cerebral hemodynamics. 
The effect of hypothermia on CBF after SAH is discussed controversially. Thome et al. [3] and 
Schubert et al. [4] demonstrated that hypothermia, induced before or immediately after cisternal blood 
injection in rats, improves CBF during cerebral perfusion pressure-independent hypoperfusion. In 
contrast, Török et al. [40] reported no change in CBF when hypothermia was induced up to 3 h after 
SAH using the endovascular perforation model in rats. The authors concluded that different sever- ities 
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of SAH in different experimental models might have contributed to these contradicting results. So far, 
two clinical reports have described CBF during hypothermia. Using positron emission tomography, 
Kawamura et al. [41] reported a decrease in CBF by 37–44 % during hypothermia in 5 patients with 
poor-grade SAH. However, the results are difficult to interpret as the CBF measurements were 
compared to normal values from normothermic volunteers. Furthermore, globally reduced CBF after 
SAH is also observed in normothermic patients [42, 43]. In the second study, Nagao et al. showed by 
means of single photon emission tomography that CBF decreased by 6.4 ml/100 g/min after induction 
of hypothermia and increased by 10.8 ml/100 g/min after rewarming in a total of 7 patients with 
cerebral vasospasm causing delayed ischemic neurological deficits. The authors noted that the 
change in CBF was detected in the region of cerebral vasospasm and CBF measurements were only 
performed if the patients’ condition allowed for technically difficult imaging studies. Therefore, the 
distinction between hypothermia- and vasospasm-related effects on CBF is difficult. For the current 
study routine TCD was used to evaluate relative changes in CBF during specific monitoring periods, 
i.e., before, during, and after hypothermia. Nevertheless, the dynamic changes during cerebral vaso- 
spasm are very likely to influence MFVMCA in particular during prolonged hypothermia. 
Cerebral vasospasm is considered an important cause of DCI and can partly be explained by the 
mismatch between vasodilatatory and -constrictor substances as well as detrimental effects of SAH-
related inflammatory reactions [44]. Animal studies have shown the potentially beneficial effects of 
hypothermia on cerebral vasospasm [3, 4, 7]. Further- more, we previously demonstrated the 
attenuation of inflammatory reactions during combined hypothermia and barbiturate coma in patients 
with severe SAH [45]. The strong correlation between elevated blood flow velocities from TCD and 
radiological evidence of cerebral vasospasm has been reported previously [28, 46]. Accordingly, we 
observed higher MFVMCA before and during early hypothermia in patients with DCI (7 of 11 patients 
with MCA vasospasm) compared to patients with intracranial hyper- tension. As mentioned above, the 
rapid changes in MFVMCA after both hypothermia induction and rewarming are unlikely to reflect the 
pathological changes in arteries occurring during cerebral vasospasm. However, the decrease in 
MFVMCA during prolonged hypothermia (on average 144 h) might suggest resolved cerebral 
vasospasm in the subgroup of patients with DCI. These findings undermine the importance of carefully 
interpreting TCD findings in SAH patients with hypothermia, because changes in Doppler blood flow 
velocity might reflect hypothermia-related changes in CBF and/or the dynamic changes during 
cerebral vasospasm. Additional temperature effects on MFVMCA during pro- longed hypothermia in 
the current study are unlikely, based on the tight temperature control (33.0–33.9 °C) using 
endovascular cooling [47]. 
The following limitations of this study need to be considered. First, the sample size of patients’ 
subgroups is small. Second, while hyperemia with high absolute CBF values has to be considered as 
differential diagnosis to cerebral vasospasm in patients with elevated flow velocities, the flow velocity 
in the extracranial internal carotid artery is not routinely measured at our institution, thus, the 
Lindegaard index could not be calculated. However, cerebral vasospasm was confirmed or excluded 
by catheter angiography in all patients. In addition, we investigated the mean differences in MFVMCA 
during specific monitoring periods, thus avoiding the difficulties of interpreting isolated TCD findings. 
Finally, we could not establish hypothermia-related changes in cerebral metabolic demands, although 
all patients were treated with bilateral extended cerebral monitoring (brain tissue oxygen tension and 
microdialysis) during prolonged hypothermia treatment. However, hypothermia was induced as early 
and fast as possible if SAH-specific complications were refractory to other therapies, a time at which 
extended cerebral monitoring was not installed in majority of patients. 
 
 
 
Conclusion 
Therapeutic hypothermia after SAH reduces MFVMCA in both intracranial hypertension and DCI 
cases. The results might reflect the physiological model of reduced CBF at lower body temperatures 
and undermine the use of TCD as a rapid and non-invasive method to monitor cerebral 
hemodynamics during hypothermia treatment. Further studies are needed to investigate flow-
metabolism coupling during hypothermia in patients with SAH. 
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